Citation Tools

Download PDFPDF

1217 Efficacy and additional mechanism of action of sacituzumab govitecan, a TROP-2 directed antibody-drug conjugate, in preclinical models of non-muscle invasive bladder cancer
Free

Download to a citation manager

Cite this article as:
Chou C, Kornyeyev D, Yang B, et al
1217 Efficacy and additional mechanism of action of sacituzumab govitecan, a TROP-2 directed antibody-drug conjugate, in preclinical models of non-muscle invasive bladder cancer